Botulinum Toxin and Dermal Fillers Market Capturing USD 9,002.9 million to have a 3.2% CAGR by 2034. Get a Glimpse into Modern Consumers’ Expectations for Cosmetic Procedures and Consumption Insights in FMI’s Study for Dermal Fillers and Botulinum Toxins!
NEWARK, Del, July 18, 2024 (GLOBE NEWSWIRE) — The dermal fillers and botulinum toxin market size is forecasted to thrive to a valuation of USD 6570.2 million in 2024 and is likely to register a CAGR of 3.2%, garnering a valuation of USD 9,002.9 million by the end of the projected period.
Increasing research and development initiatives to broaden the therapeutic botulinum toxin applications, as well as an increasing number of cosmetic issues such as lateral central lines and crow’s feet on the face, are factors driving dermal fillers and botulinum toxin market growth.
Botulinum toxin treatments are becoming increasingly popular among patients undergoing facelifts because to their low discomfort and downtime, as well as their long lasting results. Botulinum toxin has gotten particularly excellent feedback because to the low risk of adverse effects and ability to be administered numerous times per year for optimal results. This aspect is expected to drive up the dermal fillers and botulinum toxin market growth throughout the projection period.
Request a Sample Copy of this Dermal Fillers and Botulinum Toxin Market!
The demographic from 30 to 40 are frequently concerned with their physical appearance and wish to seem young which resulting into increased attention to aesthetic characteristics, particularly in developed countries, would drive the growth of the dermal fillers and botulinum toxin markets. Dermal fillers and botulinum toxins can be used to restore face volume, decrease facial rhytides, and shape facial features, resulting in an appealing, young look.
Social media has had a considerable influence on psychological health of the consumers, urging them to start the operations as soon as possible in order to minimize the beginning of age related skin issues further driving the demand for dermal fillers and botulinum toxins during the forecast period.
Current injectable therapies such as dermal fillers are becoming more popular due to their enhanced efficacy in a range of treatment settings, including cleft lip repair and neck volume restoration. Dermal fillers are used to repair acne scars, restore face volume, reduce facial rhytides, and shape facial features.
Consumers choose a less unpleasant and easier way to seem younger and have more aesthetically pleasing face characteristics. This aspect is expected to assist dermal filler and botulinum toxin producers diversify their product offerings. Major players in the dermal fillers and botulinum toxin market are increasingly focusing on producing new filler items to meet dermal fillers and botulinum toxin market regional variations and growth potential.
Key Takeaways from the Dermal Fillers and Botulinum Toxin Market:
- Australia and New Zealand is likely to augment at a CAGR of 8.6% throughout 2034.
- France is anticipated to ascend at a CAGR of 8.6% throughout 2034.
- The United States is expected to rise at a CAGR of 7.5% by 2034.
- Botulinum Toxin is projected to hold a market share of 58.4% in 2023.
- The aesthetic volume restoration segment is likely to hold a market share of 61.4% in 2023.
Top Trend Pushing Sales in Dermal Fillers and Botulinum Toxin Market:
Urgent Need to Sculpt Facial Contours Will Drive Sales in the Market
People over the age of 40 years usually focus on their physical appearance and want to look young. Therefore, it is projected that increasing attention to aesthetic traits, particularly in developed nations, will accelerate the expansion of the dermal fillers and botulinum toxin market. In order to achieve an attractive, youthful facial appearance, dermal fillers, and botulinum toxins can be used to restore facial volume, reduce facial rhytides, and sculpt facial contours.
Additionally, social media has had a significant impact on consumers’ psychological health, encouraging them to begin these procedures as soon as possible to prevent the onset of age-related skin concerns as much as possible. This factor will further propel the need for dermal fillers and botulinum toxins in the next decade.
Moreover, owing to their improved effectiveness in a variety of treatment scenarios such as cleft lip correction and neck volume restoration, modern injectable treatments like dermal fillers are becoming more popular. Dermal fillers are used to treat acne scars, restore facial volume, diminish facial rhytides, and sculpt facial contours.
Consumers prefer a less painful, easier technique to appear younger and have aesthetically appealing facial features. This factor is anticipated to help dermal fillers and botulinum toxin manufacturers diversify their product portfolios. They are increasingly focusing on launching unique filler products with rising demand among people in developed countries.
“Growing demand for minimally invasive procedures is anticipated to drive the growth of the global dermal fillers and botulinum toxin market,” Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)
Dermal Fillers and Botulinum Toxin Market Competitor Analysis and Marketing Strategies:
The global dermal fillers and botulinum toxin market is highly fragmented. Major players in the dermal fillers and botulinum toxin market are focusing on opportunities for brand differentiation and market expansion. Mergers and acquisitions activity in the industry are the key marketing strategies used by leading brands to increase their market share. Technological innovations and new product releases bring new investment opportunities in the dermal filler and botulinum toxin market.
Dermal Fillers and Botulinum Toxin Market Recent Developments:
- In January 2024, Galderma, the rising pure play dermatological category leader, announced that it has acquired clearance from Health Canada for Restylane® SHAYPE™, a hyaluronic acid injection developed for temporary chin augmentation.
- In June 2023, Merz Therapeutics, a Merz Group firm and a leader in neurotoxins, announced the opening of a new affiliate in Stockholm for the Nordic area, which includes Denmark, Sweden, and Norway. Merz Therapeutics replaced its prior distribution partner Desitin by establishing a new company in Stockholm.
Leading Dermal Fillers and Botulinum Toxin Brands:
- Allergan plc.
- Galderma SA
- Merz Pharma GmbH & Co. KGaA
- Anika Therapeutics, Inc.
- Suneva Medical, Inc.
- Speciality European Pharma
- HUGEL, Inc
- Grex Pharma SaS
- Daewoong Pharmaceuticals
- Medy-Tox Inc.
- TEOXANE Laboratories
Get in Touch with Our Sales Team to Secure Your Copy of the Report Now!
Key Segments of the Dermal Fillers and Botulinum Toxin Market Report:
By Product:
The dermal fillers and botulinum toxin market is classified into hyaluronic acid based dermal fillers, non-hyaluronic acid based dermal fillers and botulinum toxin.
By Application:
The dermal fillers and botulinum toxin market is classified into aesthetic volume restoration and wrinkle reduction.
By Region:
Analysis of the dermal fillers and botulinum toxin market has been carried out in key countries of North America, Latin America, Western Europe, South Asia, East Asia, Eastern Europe and Middle East & Africa.
About the Healthcare Domain at Future Market Insights
The Healthcare team at Future Market Insights offers expert analysis, time-efficient research, and strategic recommendations with an objective to provide authentic insights and accurate results to help clients worldwide. With a repertoire of over 100+ reports and 1 Billion+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis of key trends including competitive landscape, profit margin, and research development efforts.
Authored by:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Have a Look at the Related Report from the Dermal Fillers and Botulinum Toxin Market:
The dermal sprays market size is projected to be worth US$ 1.27 billion in 2023. The market is likely to surpass US$ 2.81 billion by 2033 at a CAGR of 8.3% during the forecast period.
The global face and ear bows market was valued at around US$ 230.9 Mn at the end of 2021. The market is projected to register a 5.5% CAGR and top a valuation of US$ 394.4 Mn by 2032.
The global intradermal injection market is expected to surpass an impressive valuation of US$ 3,878 Million in 2022 and is projected to exhibit a compound annual growth rate (CAGR) of 10.8% from 2022 to 2032.
Primary research consultants at FMI’s healthcare domain project that the global surface plasmon resonance system market is poised to reach a valuation of US$ 1.0 billion by 2024.
The global dermal filler market size is estimated to reach a valuation of US$ 6,411.8 million in 2024. The market is projected to surpass US$ 8,764.6 million by 2034, registering a promising CAGR of 3.2%.
The global surface disinfectant market is estimated to reach a valuation of US$ 8,095.5 million in 2024. The surface disinfectant market size is expected to surpass US$ 39,419.3 million by 2034.
Demand for dermal fillers in Europe market is set to grow by 4.5% from 2023 to 2033 with an estimated market value of around US$ 1.63 Billion as of 2023.
The medical face shield market is anticipated to be worth US$ 517.9 million in 2024. The market is expected to register at a rate of CAGR 4.6% through 2034.
According to Future Market Insights (FMI), analysis in a recent market survey estimated that the global botulinum toxin-coated microneedles market will be valued at US$ 109.6 Million in 2024
The global non-hyaluronic acid dermal filler market size is expected to reach US$ 520.4 Million by 2032.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
